Compare Cipta Sarana Medika Tbk. (DKHH) vs Saraswanti Indoland Development Tbk. (SWID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Saraswanti Indoland Development Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B), while Saraswanti Indoland Development Tbk. trades at Rp93 (market cap 500.81B). The key difference: Saraswanti Indoland Development Tbk. is far larger — about 3.1× Cipta Sarana Medika Tbk.'s market cap. Which is the better fit depends on your goals.
| DKHH | SWID | |
|---|---|---|
Market Cap | 160.67B | 500.81B |
Indicative Equilibrium Price | 63 | 93 |
Indicative Equilibrium Volume | 220 | 531 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Saraswanti Indoland Development Tbk.
PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →
